Clinical Trials List
Protocol NumberSPC-MU-201903
Active
2025-05-01 - 2027-12-31
Phase IV
Recruiting1
ICD-10E83.00
Disorder of copper metabolism, unspecified
ICD-10E83.01
Wilson's disease
ICD-10E83.09
Other disorders of copper metabolism
ICD-9275.1
Disorders of copper metabolism
-
Trial Applicant
SHINER PHARM CORP.
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 吳逸如 Division of Neurology
- Hsiu-Chuan Wu Division of Neurology
- Chi-Hung Liu Division of Neurology
- 張庭瑜 Division of Neurology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
24 participants
-
Global
24 participants
